Skip to main content

Table 1 Comparison of clinical baseline data between SYNTAX low and medium/high risk group [n(%),M(P25--P75)]

From: Prognosis evaluation of universal acute coronary syndrome: the interplay between SYNTAX score and ApoB/ApoA1

Item Low-risk group
(0–22)
Medium/high risk group
(≥23)
p
n 33165 
GenderMale224(67.7)50(76.9)0.140
 Female107(32.3)15(23.1) 
In-hospital ventricular fibrillation 1(0.3)01.000
In-hospital ventricular tachycardia 2(0.6)1(1.5)0.417
In-hospital atrial fibrillation 6(1.8)3(4.6)0.170
In-hospital heart failure 52(15.7)18(27.7)0.021
Hypertension 211(63.7)40(61.5)0.736
Diabetes 62(18.7)17(26.2)0.171
CHD history 61(18.4)10(15.4)0.559
Myocardial infarction history 22(6.6)6(9.2)0.432
PCI history 18(5.4)6(9.2)0.255
Smoking history 192(58.0)35(53.8)0.535
Age(years old) 58.84 ± 10.2760.23 ± 9.830.340
BMI(kg/m2) 25.37 ± 3.9324.83 ± 4.390.349
Ejection fraction(%) 58.87 ± 10.8356.12 ± 10.900.103
ApoB/ApoA1High risk9(2.7)6(9.2)0.023
 Low risk322(97.3)59(90.8) 
ApoB/ApoA1 0.91(0.71–1.04)0.94(0.76–1.05)0.152
TG(mmol/l) 1.73(1.0–2.13)1.78(1.14–2.30)0.267
LDL-c(mmol/l) 3.13(2.46–3.65)3.17(2.46–3.70)0.727
Non HDL-c(mmol/l) 3.5(2.77–4.10)3.62(2.94–4.05)0.464
Hb(g/L) 140.81(131–153)140.5(129–155)0.976
PLT(× 109/L) 205.2(166–238)193.01(157.5–227.5)0.182
HCT(L/L) 0.93(0.39–0.45)0.42(0.39–0.46)0.768
LM 16(4.8)16(24.6)< 0.001
PLAD 216(65.3)55(84.6)< 0.001
MLAD 173(52.3)38(58.5)0.415
RCX 224(67.7)56(86.2)< 0.001
RCA 267(80.7)59(90.8)0.052
RAM 5(1.5)2(3.1)0.323
Number of lesions treated 1.38 ± 0.661.55 ± 0.730.032
Number of stents implanted 1.49 ± 0.901.59 ± 1.00.345
Maximum stent diameter(mm) 3.32 ± 0.493.24 ± 0.460.134